STROMALab Médecine régénératrice, thérapie cellulaire, cellules souches mésenchymateuses, tissu adipeux, moelle osseuse, réparation, régénération Regenerative medicine, cell therapy, mesenchymal stem cells, adipose tissue, bone marrow, repair, regeneration

Keyword : "hypoxia" » 3 results

Publications » FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model.

  |  , , ,

Gstalder C, Ader I*, Cuvillier O*. Mol Cancer Ther. *Co-corresponding authors


Publications » Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer.

  |  , , ,

Bouquerel P, Gstalder C, Müller D, Laurent J, Brizuela L, Sabbadini RA, Malavaud B, Pyronnet S, Martineau Y, Ader I*, Cuvillier O*. Oncogenesis. *Co-corresponding authors


Publications » Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer.

  |  , , ,

Ader I, Gstalder C, Bouquerel P, Golzio M, Andrieu G, Zalvidea S, Richard S, Sabbadini RA, Malavaud B, Cuvillier O. Oncotarget.

STROMALAB

CHU TOULOUSE – HÔPITAL DE RANGUEIL

Bât L1, 2ème étage

1 avenue Jean Poulhès – BP 84225

31432 TOULOUSE CEDEX 4

Phone : +33 5 61 28 37 21

Contact us

Actuality

Loïc FIEVET wins the oral communication award at the 17th SFGM-TC Congress

20 November 2017 |  

Our Doctoral student Loïc Fiévet was awarded the prize for oral communication at the 17th SFGM-TC Congress - Société Francophone de...


Computational Epigenomics Tools to Understand the Cellular Language of Pluripotency and Reprogramming

12 October 2017 |  

Dr. Marcos Arauzo-Bravo, Director of the bioinformatics platform of the bio-medical research institute of "Donostia" (San Sebastián), will present what he...


Human bone regeneration conference

12 October 2017 |  

Dr. Pierre Layrolle, Director of INSERM 1238 "Phy-OS" of the Faculty of Medicine of of Nantes, will be coming to give...

See all